Skip to main page content

. 2011 Apr;29(4):301.

doi: 10.1038/nbt0411-301.

p38 kinase inhibitor approved for idiopathic pulmonary fibrosis

PMID: 21478838
DOI: 10.1038/nbt0411-301

p38 kinase inhibitor approved for idiopathic pulmonary fibrosis

Nuala Moran. Nat Biotechnol. 2011 Apr.

. 2011 Apr;29(4):301.

doi: 10.1038/nbt0411-301.

Author

PMID: 21478838
DOI: 10.1038/nbt0411-301

No abstract available

PubMed Disclaimer

Similar articles

Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases.
Chopra P, Kanoje V, Semwal A, Ray A. Chopra P, et al. Expert Opin Investig Drugs. 2008 Oct;17(10):1411-25. doi: 10.1517/13543784.17.10.1411. Expert Opin Investig Drugs. 2008. PMID: 18808304 Review.
Medications for Idiopathic Pulmonary Fibrosis: IPF Part 2.
Guler SA, Lindell KO, Swigris J, Ryerson CJ. Guler SA, et al. Am J Respir Crit Care Med. 2021 Feb 1;203(3):P7-P8. doi: 10.1164/rccm.2033P7. Am J Respir Crit Care Med. 2021. PMID: 33522880 No abstract available.
Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies.
Kaner RJ, Bajwa EK, El-Amine M, Gorina E, Gupta R, Lazarus HM, Luckhardt TR, Mouded M, Posada K, Richeldi L, Stauffer J, Tutuncu A, Martinez FJ. Kaner RJ, et al. Am J Respir Crit Care Med. 2019 Jul 15;200(2):133-139. doi: 10.1164/rccm.201903-0592PP. Am J Respir Crit Care Med. 2019. PMID: 30985215 No abstract available.
Nintedanib - efficacy, safety and practical aspects of treatment for patients with idiopathic pulmonary fibrosis.
Martusewicz-Boros M, Górska K. Martusewicz-Boros M, et al. Adv Respir Med. 2020;88(6):599-607. doi: 10.5603/ARM.a2020.0190. Adv Respir Med. 2020. PMID: 33393653 Review.
Pirfenidone inhibits p38-mediated generation of procoagulant microparticles by human alveolar epithelial cells.
Neri T, Lombardi S, Faìta F, Petrini S, Balìa C, Scalise V, Pedrinelli R, Paggiaro P, Celi A. Neri T, et al. Pulm Pharmacol Ther. 2016 Aug;39:1-6. doi: 10.1016/j.pupt.2016.05.003. Epub 2016 May 26. Pulm Pharmacol Ther. 2016. PMID: 27237042

See all similar articles

Cited by

Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice.
Li H, Xu M, Chen D, Wen W, Luo J. Li H, et al. Front Oncol. 2024 Mar 25;14:1351839. doi: 10.3389/fonc.2024.1351839. eCollection 2024. Front Oncol. 2024. PMID: 38590657 Free PMC article.
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.
Fortier SM, Walker NM, Penke LR, Baas JD, Shen Q, Speth JM, Huang SK, Zemans RL, Bennett AM, Peters-Golden M. Fortier SM, et al. J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.
Identification of Potential p38γ Inhibitors via In Silico Screening, In Vitro Bioassay and Molecular Dynamics Simulation Studies.
Cheng Z, Bhave M, Hwang SS, Rahman T, Chee XW. Cheng Z, et al. Int J Mol Sci. 2023 Apr 17;24(8):7360. doi: 10.3390/ijms24087360. Int J Mol Sci. 2023. PMID: 37108523 Free PMC article.
Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis.
Ligresti G, Raslan AA, Hong J, Caporarello N, Confalonieri M, Huang SK. Ligresti G, et al. Gene. 2023 Apr 5;859:147142. doi: 10.1016/j.gene.2022.147142. Epub 2023 Jan 2. Gene. 2023. PMID: 36603696 Free PMC article. Review.
Pathophysiological Roles of Stress-Activated Protein Kinases in Pulmonary Fibrosis.
Kasuya Y, Kim JD, Hatano M, Tatsumi K, Matsuda S. Kasuya Y, et al. Int J Mol Sci. 2021 Jun 3;22(11):6041. doi: 10.3390/ijms22116041. Int J Mol Sci. 2021. PMID: 34204949 Free PMC article. Review.

See all "Cited by" articles

References

1. Nat Biotechnol. 2009 Sep;27(9):781-3 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- Genetic Alliance